AAAAAA

   
Results: 1-8 |
Results: 8
A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats
Authors: Greenberger, LM Annable, T Collins, KI Komm, BS Lyttle, CR Miller, CP Satyaswaroop, PG Zhang, YX Frost, P
Citation: Lm. Greenberger et al., A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats, CLIN CANC R, 7(10), 2001, pp. 3166-3177
6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity
Authors: Tsou, HR Mamuya, N Johnson, BD Reich, MF Gruber, BC Ye, F Nilakantan, R Shen, R Discafani, C DeBlanc, R Davis, R Koehn, FE Greenberger, LM Wang, YF Wissner, A
Citation: Hr. Tsou et al., 6-Substituted-4-(3-bromophenylamino)quinazolines as putative irreversible inhibitors of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor (HER-2) tyrosine kinases with enhanced antitumor activity, J MED CHEM, 44(17), 2001, pp. 2719-2734
Design, synthesis, and preclinical characterization of novel, highly selective indole estrogens
Authors: Miller, CP Collini, MD Tran, BD Harris, HA Kharode, YP Marzolf, JT Moran, RA Henderson, RA Bender, RHW Unwalla, RJ Greenberger, LM Yardley, JP Abou-Gharbia, MA Lyttle, CR Komm, BS
Citation: Cp. Miller et al., Design, synthesis, and preclinical characterization of novel, highly selective indole estrogens, J MED CHEM, 44(11), 2001, pp. 1654-1657
4-Anilino-6,7-dialkoxyquinolime-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors
Authors: Wissner, A Berger, DM Boschelli, DH Floyd, MB Greenberger, LM Gruber, BC Johnson, BD Mamuya, N Nilakantan, R Reich, MF Shen, R Tsou, HR Upeslacis, E Wang, YF Wu, BQ Ye, F Zhang, N
Citation: A. Wissner et al., 4-Anilino-6,7-dialkoxyquinolime-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitors, J MED CHEM, 43(17), 2000, pp. 3244-3256
Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein
Authors: Rabindran, SK Ross, DD Doyle, LA Yang, WD Greenberger, LM
Citation: Sk. Rabindran et al., Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein, CANCER RES, 60(1), 2000, pp. 47-50
Fumitremorgin C analogs that reverse mitoxantrone resistance in human colon carcinoma cells
Authors: He, HY Rabindran, SG Greenberger, LM Carter, GT
Citation: Hy. He et al., Fumitremorgin C analogs that reverse mitoxantrone resistance in human colon carcinoma cells, MED CHEM RE, 9(6), 1999, pp. 424-437
Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)
Authors: Discafani, CM Carroll, ML Floyd, MB Hollander, IJ Husain, Z Johnson, BD Kitchen, D May, MK Malo, MS Minnick, AA Nilakantan, R Shen, R Wang, YF Wissner, A Greenberger, LM
Citation: Cm. Discafani et al., Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with in vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785), BIOCH PHARM, 57(8), 1999, pp. 917-925
Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C
Authors: Rabindran, SK He, HY Singh, M Brown, E Collins, KI Annable, T Greenberger, LM
Citation: Sk. Rabindran et al., Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C, CANCER RES, 58(24), 1998, pp. 5850-5858
Risultati: 1-8 |